July 12, 2016

A new survey by Iowa-based Meyocks has found that Americans place a lot of trust in pharmacists — and a little bit less in doctors and dentists.

July 11, 2016

The American Pharmacists Association has developed an overview of requirements and a more detailed summary that highlights key aspects of the rule and requirements relevant to pharmacists.

July 11, 2016

Vollmer, who has been Iroko’s president since March 2015 has been in the pharmaceutical industry for more than 25 years, including his role as one of three founders of Endo Pharmaceuticals.

July 8, 2016

Xolair can now be used in patients 6 to 11 years of age with moderate to severe persistent allergic asthma. 

July 8, 2016

Fred’s said that it offers year-round immunizations for the flu, measles, shingles and pneumonia, among others, in addition to its medication synchronization program and 90-day prescription services.

July 8, 2016

The Little Clinic first opened in the Toledo region in early 2015 and now operates four clinics in the area.

July 8, 2016

The announcement builds on NACDS’ recent extension of a national tour for another training program of promise for public health: a train-the-trainer program for administering point-of-care testing in community pharmacies.

July 8, 2016

The Centers for Medicare & Medicaid Services has revoked the Theranos' CLIA certificate, among other sanctions.

July 7, 2016

Diplomat’s Kelly Procailo joins the ranks of the 1,900 people who've received a Board Certified Oncology Pharmacist certification. 

July 7, 2016

Fred's CEO Jerry Shore said the company saw strong performance in front-end categories in June, but not enough to offset lower pharmacy sales.

July 7, 2016
Canada's health minister has signed an order allowing access to Narcan (naloxone) nasal spray as the government conducts an expedited review of the product. 
July 7, 2016

Each winner has been awarded a $1,500 scholarship, totaling $13,500 in IPC future independent pharmacy support.

July 7, 2016

In addition to a significant reduction in readmissions, the health plan savings doubled the initial investment into the program.

July 7, 2016

Patients can now see a MinuteClinic nurse practitioner or physician assistant for a pre-travel risk assessment in advance of their trip and receive an individualized plan for prevention and treatment.

July 7, 2016

Taro Pharmaceuticals on Thursday announced that its CEO Kal Sundaram would be stepping down as CEO at the end of 2016. 

July 6, 2016

Mylan’s fenofibrate tablets will be available in 40- and 120-mg dosage strengths. 

July 5, 2016
Last year, Benzer introduced its Dispose My Meds prescription drug take-back program in partnership with the National Community Pharmacists Association, but patients could not use it for controlled substances. 
July 5, 2016

The Most Valuable Pharmacy award is given by the Independent Pharmacy Cooperative to recognize a pharmacy in the cooperative that is engaged and uses a vast array of its programs and contracts.

July 5, 2016

For the quarter, the company saw revenues of $723.6 million — a 1.6% rise over the same quarter last year that it attributes to overall market growth and the expansion of its franchised store network.

July 1, 2016

The settlement that was overturned had been approved by a judge in 2013, and was the result of a 2005 lawsuit brought by 19 retailers and trade associations but 10 of the plaintiffs, including all of the associations, rejected the settlement when it was unveiled in 2012. 

July 1, 2016
Humira was first approved in 2003, and has since been approved in more than 90 countries. 
July 1, 2016
NACDS and NCPA urged the Senate committee to adopt the House’s position in its version of the National Defense Authorization Act , which does not include provisions that would increase TRICARE copays, arguing that higher copays can have detrimental effects on patient health and federal spending. 
 
July 1, 2016

The University at Buffalo is launching a pre-pharmacy summer camp for high school students across the United States who are interested in pursuing the profession.

June 30, 2016
Epclusa, which treats all genotypes of hepatitis C, received Priority Review and Breakthrough Therapy designations from the FDA.